Inventor · disambiguated record
Frederick Woolf Goldberg
Also filed as: GOLDBERG FREDERICK · GOLDBERG FREDERICK WOOLF
10 granted patents·8 pending applications·9 citations·filing 2008–2025
83Inventor score
Top patents by PatentIndex Score
18 records- 0189US11136340B2Amino-triazolopyridine compounds and their use in treating cancerASTRAZENECA AB·Filed 2019·Granted Oct 5, 2021·3 cites·28 claims
- 0288US10407446B2Amino-triazolopyridine compounds and their use in treating cancerASTRAZENECA AB·Filed 2017·Granted Sep 10, 2019·3 cites·14 claims
- 0383US11084827B2Triazolopyrimidine compounds and their use in treating cancerDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2020·Granted Aug 10, 2021·1 cites·18 claims
- 0480US2024124492A1Amino-triazolopyridine Compounds and Their Use in Treating CancerASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 0579US12503473B2Triazolopyrimidine compounds and their use in treating cancerDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2023·Granted Dec 23, 2025·0 cites·6 claims
- 0675US11746118B2Amino-triazolopyridine compounds and their use in treating cancerASTRAZENECA AB·Filed 2021·Granted Sep 5, 2023·0 cites·20 claims
- 0770US11851432B2Triazolopyrimidine compounds and their use in treating cancerDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2021·Granted Dec 26, 2023·0 cites·20 claims
- 0868US10597405B2Chemical compoundsASTRAZENECA AB·Filed 2018·Granted Mar 24, 2020·1 cites·18 claims
- 0968US2024247001A12,6,9-trisubstituted purinesASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 1065US2024150355A1Purinone compounds and their use in treating cancerASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 1164US12441744B22,6,9-trisubstituted purinesASTRAZENECA AB·Filed 2025·Granted Oct 14, 2025·0 cites·19 claims
- 1264US11884671B2Purinone compounds and their use in treating cancerASTRAZENECA AB·Filed 2019·Granted Jan 30, 2024·1 cites·22 claims
- 1362US2025177539A1Er degraders and uses thereofASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 1457US11407765B2Tetracyclic heteroaryl compoundsASTRAZENECA AB·Filed 2019·Granted Aug 9, 2022·0 cites·19 claims
- 1557US2024374606A1Substituted pyrazine-2-carboxamides as hpk1 inhibitors for the treatment of cancerASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 1647US2009048269A1Chemical compounds-821ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1736US2011251173A1Chemical compoundsASTRAZENECA AB·Filed 2011·Application pending·0 cites
- 1834US2011092526A1Adamantyl Iminocarbonyl-Substituted Pyrimidines As Inhibitors Of 11-Beta-HSD1 826ASTRAZENECA AB·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →